These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2316495)

  • 41. Determinants of total high density lipoprotein cholesterol and high density lipoprotein subfraction levels among Hispanic and non-Hispanic white persons with normal glucose tolerance: the San Luis Valley Diabetes Study.
    Fulton-Kehoe DL; Eckel RH; Shetterly SM; Hamman RF
    J Clin Epidemiol; 1992 Nov; 45(11):1191-200. PubMed ID: 1359022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.
    Young MJ; Boulton AJ; MacLeod AF; Williams DR; Sonksen PH
    Diabetologia; 1993 Feb; 36(2):150-4. PubMed ID: 8458529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 'VPTscore'--a useful predictor of neuropathy in diabetic patients.
    Coppini DV; Weng C; Young PJ; Sönksen PH
    Diabet Med; 2000 Jun; 17(6):488-90. PubMed ID: 10975223
    [No Abstract]   [Full Text] [Related]  

  • 44. Age as an independent factor for the development of neuropathy in diabetic patients.
    Popescu S; Timar B; Baderca F; Simu M; Diaconu L; Velea I; Timar R
    Clin Interv Aging; 2016; 11():313-8. PubMed ID: 27042031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study.
    Iyengar S; Hamman RF; Marshall JA; Majumder PP; Ferrell RE
    Genet Epidemiol; 1989; 6(6):691-8. PubMed ID: 2691326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropathy in non-insulin-dependent diabetes mellitus. The significance of symptoms.
    Hong CY; Chia SE; Fong SK
    Scand J Prim Health Care; 1998 Dec; 16(4):233-7. PubMed ID: 9932317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. San Luis Valley Diabetes Study.
    Boyko EJ; Keane EM; Marshall JA; Hamman RF
    Diabetes; 1991 Apr; 40(4):509-15. PubMed ID: 2010052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy.
    Novella SP; Inzucchi SE; Goldstein JM
    Muscle Nerve; 2001 Sep; 24(9):1229-31. PubMed ID: 11494278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
    Olaleye D; Perkins BA; Bril V
    Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperglycemia as a major determinant of distal polyneuropathy independent of age and diabetes duration in patients with recently diagnosed diabetes.
    Matsumoto T; Ohashi Y; Yamada N; Kikuchi M
    Diabetes Res Clin Pract; 1994 Dec; 26(2):109-13. PubMed ID: 7705191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of autonomic and peripheral neuropathy in insulin-treated diabetic subjects.
    Flynn MD; O'Brien IA; Corrall RJ
    Diabet Med; 1995 Apr; 12(4):310-3. PubMed ID: 7600745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study.
    Mayer-Davis EJ; Bell RA; Reboussin BA; Rushing J; Marshall JA; Hamman RF
    Ophthalmology; 1998 Dec; 105(12):2264-70. PubMed ID: 9855158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal effects of one-leg standing time on neuropathy outcomes in association with glycemic control in non-elderly patients with type 2 diabetes.
    Sugimoto K; Sozu T; Hoshino T; Watanabe Y; Tamura A; Yamazaki T; Ohta S; Suzuki S; Shimbo T
    J Diabetes Investig; 2022 Jun; 13(6):1039-1051. PubMed ID: 35044110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Painful neuropathy and foot ulceration in diabetic patients.
    Veves A; Manes C; Murray HJ; Young MJ; Boulton AJ
    Diabetes Care; 1993 Aug; 16(8):1187-9. PubMed ID: 8375249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
    Herman WH; Pop-Busui R; Braffett BH; Martin CL; Cleary PA; Albers JW; Feldman EL;
    Diabet Med; 2012 Jul; 29(7):937-44. PubMed ID: 22417277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population.
    Harris M; Eastman R; Cowie C
    Diabetes Care; 1993 Nov; 16(11):1446-52. PubMed ID: 8299433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between HbA
    Peterson M; Pingel R; Lagali N; Dahlin LB; Rolandsson O
    Diabet Med; 2017 Dec; 34(12):1756-1764. PubMed ID: 28929513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of neuropathy in patients with impaired glucose tolerance using various electrophysiological tests.
    Kannan MA; Sarva S; Kandadai RM; Paturi VR; Jabeen SA; Borgohain R
    Neurol India; 2014; 62(6):656-61. PubMed ID: 25591680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential risk factors for diabetic neuropathy: a case control study.
    Booya F; Bandarian F; Larijani B; Pajouhi M; Nooraei M; Lotfi J
    BMC Neurol; 2005 Dec; 5():24. PubMed ID: 16336693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.